Which induction therapy for potentially resectable cases?

Date 07 October 2016
Event ESMO 2016 Congress
Session Optimal treatment of stage III NSCLC
Topics Cytotoxic agents
Surgical oncology
Non-small-cell lung cancer
Therapy
Biological therapy
Radiation oncology
Presenter Wilfried Eberhardt
Authors W.E. Eberhardt
  • Dept. Medical Oncology, University Hospital Essen Westdeutsches Tumorzentrum, 45122 - Essen/DE